Skip to main content

Antalpha Reports Fourth Quarter and Full Year 2025 Results

SINGAPORE, March 03, 2026 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (NASDAQ: ANTA) (“Antalpha” or the “Company”) today announced its unaudited financial results for the fourth quarter and fiscal year ended December 2025. “Antalpha finished 2025 on a solid footing. As a crypto-native financing platform with tokenized gold upside, our Q4 revenue grew 110% from last year with increasing profitability. Our solid momentum throughout 2025, weathering Bitcoin’s volatility, reinforces Antalpha’s strategic positioning as a leading collateralized lending platform. We enable clients to navigate inherent Bitcoin volatility with strong risk management that reaps rewards for our clients and ultimately our shareholders,” said Paul Liang, CFO of Antalpha. “Our broader long-term product roadmap is to increase...

Continue reading

Strata Critical Medical Announces Fourth Quarter 2025 Results

Revenue increased 83.5% year-over-year to $66.8 million in Q4 2025 Logistics revenue and gross profit grew 35.3% and 39.5% year-over-year, respectively, in Q4 2025, which represents Strata’s organic growth Full year 2025 net loss from continuing operations was $20.1 million Full year 2025 revenue and Adjusted EBITDA(1) of $197.1 million and $14.1 million, respectively, both beat the high end of our guidance range Raising full year 2026 revenue guidance to between $260 and $275 million and Adjusted EBITDA guidance to between $29 and $33 million(2)NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) — Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced financial results for the fourth quarter ended December 31, 2025. Financial results in this release, including all comparisons...

Continue reading

Marex Group plc announces fourth quarter and full year 2025 results

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) — Marex Group plc (‘Marex’ or the ‘Group’; Nasdaq: MRX) a diversified global financial services platform, providing essential liquidity, market access and infrastructure services to clients in the energy, commodities and financial markets, today reported the Group’s preliminary unaudited financial results for the fourth quarter (‘Q4 2025’). Ian Lowitt, Group Chief Executive Officer, stated, “This was a record fourth quarter for Marex, marked by a strong, broad-based performance, supportive market conditions and high levels of client activity. This included growing engagement with larger clients, which reflects our strengthening competitive position. Quarterly revenue increased 38% to $572.1 million, Adjusted Profit Before Tax¹ rose 41% to $114.9 million, and earnings per share...

Continue reading

Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights

Enrolled first three FTD-GRN patients in Cohort 3 of ongoing upliFT-D study Treated first FTD-C9orf72 patient with Dose 2 PBFT02 in Cohort 4 of upliFT-D study On track to report updated interim safety and biomarker data from upliFT-D and obtain regulatory feedback on FTD-GRN registrational trial design in 1H 2026 Advancing differentiated preclinical program for Huntington’s with clinical candidate selection expected in 2H 2026 Cash runway through 1Q 2027 PHILADELPHIA, March 03, 2026 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today reported financial results for the fourth quarter and year ended December 31, 2025, and provided recent business highlights. “We are proud of the progress made in 2025 as we...

Continue reading

EVgo Inc. Reports Record Fourth Quarter and Full Year 2025 Results

Total Q4 Revenues Increased 75% with Record Charging Network Revenue of $64 MillionInitiates 2026 guidance of $410 – $470 Million of Revenue and $(20) – $20 Million of Adjusted EBITDA1Total revenue of $118 million in the fourth quarter, representing an increase of 75% year-over-year. For the full year 2025, revenue reached $384 million, an increase of 50% over the full year 2024. Charging network revenue totaled a record $64 million in the fourth quarter, an increase of 37% year-over-year, representing the 16th consecutive quarter of double-digit year-over-year charging revenue growth. For the full year 2025, charging network revenue reached $218 million, an increase of 40% over the full year 2024. Network throughput reached 99 gigawatt-hours (“GWh”) in the fourth quarter, an increase of 18% year-over-year. Network throughput...

Continue reading

Advantage Solutions Reports Fourth Quarter and Full Year 2025 Results

  Strong cash flow performance resulted in ending the quarter with $241 million of cash, up $40 million sequentially    Completion of non-core divestitures, planned debt refinancing and upcoming reverse stock split    Expect flat to up low-single digit revenue growth in 2026, Adjusted EBITDA flat to down mid-single digits    ST. LOUIS, March 03, 2026 (GLOBE NEWSWIRE) — Advantage Solutions Inc. (NASDAQ: ADV) (“Advantage,” “Advantage Solutions,” the “Company,” “we,” or “our”), a leading business solutions provider to consumer goods manufacturers and retailers, today reported financial results for the three and twelve months ended December 31, 2025. Unless otherwise noted, results presented in this release are from continuing operations, and comparisons are on a prior year basis. Revenues for the three months ended December 31, 2025...

Continue reading

Sportradar Reports Fourth Quarter and Full Year 2025 Financial Results, and Announces Significant Expansion in Share Repurchase Plan to $1 Billion

Full Year 2025 HighlightsRevenue increased 17% to a record €1,290 million Generated profit for the period of €100 million, 7.8% as a percentage of revenue Adjusted EBITDA1 increased 33% to a record €297 million and Adjusted EBITDA margin1 expanded 291 basis points to 23.0% Generated net cash from operating activities of €403 million and record Free cash flow1 of €167 million Repurchased $91 million of shares and announced significant increase in share repurchase plan bringing total authorization from $300 million to $1 billion Achieved a Customer Net Retention Rate1 of 109% Completed the acquisition of IMG ARENA and its global sports betting rights portfolioFourth Quarter 2025 HighlightsRevenue increased 20% to €369 million Generated profit for the period of €4 million, 1.2% as a percentage of revenue Adjusted EBITDA increased 48%...

Continue reading

AutoZone 2nd Quarter Total Company Same Store Sales Increase 3.3%; Domestic Same Store Sales Increase 3.4%; EPS of $27.63

MEMPHIS, Tenn., March 03, 2026 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE: AZO) today reported net sales of $4.3 billion for its second quarter (12 weeks) ended February 14, 2026, an increase of 8.1% from the second quarter of fiscal 2025 (12 weeks). Same store sales, or sales for our domestic and international stores open at least one year, are as follows:      Constant Currency       Constant Currency  12 Weeks   12 Weeks*   24 Weeks   24 Weeks*               Domestic 3.4 %   3.4 %   4.2 %   4.2 %International 17.1 %   2.5 %   14.2 %   3.1 %Total Company 5.2 %   3.3 %   5.4 %   4.0 %* Excludes impacts from fluctuations of foreign exchange rates. For the quarter, gross profit, as a percentage of sales, was 52.5%, a decrease of 137 basis points versus the prior year. The decrease in gross margin was driven...

Continue reading

Pet Valu Reports Fourth Quarter and Fiscal Year 2025 Results

Grows 2025 Revenue 7%, Adjusted EBITDA(1) 4% and Net Income 12% Raises Quarterly Dividend 8% and Issues 2026 Outlook MARKHAM, Ontario, March 03, 2026 (GLOBE NEWSWIRE) — Pet Valu Holdings Ltd. (“Pet Valu” or the “Company”) (TSX: PET), the leading Canadian specialty retailer of pet food and pet-related supplies, today announced its financial results for the fourth quarter and fiscal year ended January 3, 2026. Fourth Quarter HighlightsSystem-wide sales(2) were $423.7 million, an increase of 9.2% versus Q4 2024. Same-store sales growth(2) was 0.3%. Revenue was $326.4 million, up 10.6% versus Q4 2024. Adjusted EBITDA was $74.6 million, up 9.4% versus Q4 2024, representing 22.9% of revenue. Operating income was $48.1 million, up 0.5% versus Q4 2024. Adjusted Net Income(1) was $34.0 million or $0.49 per diluted share(3), compared to...

Continue reading

Marquette National Corporation Reports 2025 Annual Results

CHICAGO, March 03, 2026 (GLOBE NEWSWIRE) — Marquette National Corporation (OTCQX: MNAT) today reported net income of $13.2 million for the year ended December 31, 2025, compared to net income of $17.1 million for the year ended December 31, 2024. The Company recorded earnings per share of $3.01 for 2025 as compared to earnings of $3.91 per share for the year ended December 31, 2024. At December 31, 2025, total assets were $2.22 billion, an increase of $17 million, or 1%, compared to $2.21 billion at December 31, 2024. Total loans increased by $7 million to $1.412 billion compared to $1.405 billion at the end of 2024. Total deposits increased by $34 million, or 2%, to $1.77 billion compared to $1.74 billion at the end of 2024. Paul M. McCarthy, Chairman & CEO, said, “the primary reason for the decrease in consolidated earnings...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.